A study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of surovatamig in adult participants with rheumatoid arthritis or systemic lupus erythematosus.
D740AC00001
Phase 1 other active
Quick answer
A study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of surovatamig in adult participants with rheumatoid arthritis or systemic lupus erythematosus. for Systemic Lupus Erythematosus, Rheumatoid Arthritis is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Systemic Lupus Erythematosus, Rheumatoid Arthritis
- Phase
- Phase 1
- Modality
- other
- Status
- active